Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this registration statement on the Post-Effective Amendment No. 2 to Form S-1 of DelMar Pharmaceuticals, Inc. of our report dated August 28, 2014 relating to the financial statements of DelMar Pharmaceuticals, Inc., which appears in the Post-Effective Amendment No. 2 to Form S-1. We also consent to the references to us under the heading “Experts” in such registration statement.
/s/ PricewaterhouseCoopers LLP
Chartered Accountants
March 6, 2015